Rheumatoid Arthritis of the Foot & Ankle — assessment and management in Brisbane
More than 90% of people with rheumatoid arthritis develop foot and ankle symptoms over the course of the disease, and in about one in five the feet are where it first appears. Foot care runs alongside rheumatology-directed treatment rather than replacing it.

Rheumatoid arthritis is an autoimmune disease in which the immune system attacks the lining of the joints, damaging cartilage and ligaments and softening bone. The feet are involved in the great majority of people at some stage, and the pattern is distinctive: symptoms in both feet, affecting the same joints on each side, rather than the single-joint picture typical of osteoarthritis. Weakened ligaments and softened bone drive the characteristic deformities — a collapsing arch, bunions, claw toes and painful prominences under the ball of the foot.

Assessment covers where the pain actually is, since the joints that look worst on X-ray are not always the ones generating symptoms. Examination looks at the pattern of calluses as a map of abnormal pressure, the shape of the foot, whether the affected joints still move, and tenderness in specific joints. X-rays document alignment; CT or MRI are used selectively where the deformity is severe or a tendon problem is suspected. Where inflammatory arthritis is newly suspected, blood tests and urgent rheumatology referral matter — early disease-modifying treatment is the single biggest determinant of long-term joint outcomes, and normal blood results do not exclude the diagnosis.

First-line foot care is about reducing load and pressure: lower-impact activity such as swimming or cycling, ice after activity, custom orthoses made of softer material to offload prominent bones, supportive footwear with a more rigid sole, and a lace-up or custom-moulded brace for hindfoot and ankle pain. Corticosteroid injection into an affected joint can help in earlier stages and sometimes clarifies which joint is responsible. Podiatry has an established role here and is accessible through chronic disease management arrangements. Surgery — usually fusion, and sometimes ankle replacement — is considered when cartilage damage is advanced and non-surgical measures have been exhausted. Any skin breakdown or ulceration over a bony prominence, or a hot swollen joint with fever in someone on immunosuppressive medication, needs prompt review.

Common symptoms

  • Pain, swelling and stiffness in the same joints of both feet
  • Difficulty with ramps, stairs or walking on uneven ground
  • A collapsing arch or a change in the shape of the foot
  • Bunions, claw toes, and painful calluses under the ball of the foot
Every treatment reviewed for this diagnosis

Evidence for twelve treatment options in rheumatoid arthritis of the foot & ankle

This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.

Foundation — diagnosis, education and rehabilitation

The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.

Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care

What it involves

Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan — with weight management where that is clinically relevant.

What the evidence shows

Exercise and education sit alongside medical disease control, not instead of it. Both the ASAS-EULAR recommendations and the American College of Rheumatology guideline place education, regular exercise and physical therapy as core non-pharmacological management in axial spondyloarthritis, escalating to a biologic where disease activity stays high (Ramiro, Ann Rheum Dis 2023; Ward, Arthritis Rheumatol 2019).

Pairing reviewed 2026-09-02.

Where it fits for you

The critical point is sequencing: this does not replace rheumatological treatment, and a delay in getting disease control is the thing that causes lasting damage. Assessment here is aimed at recognising the pattern early and getting you to the right treatment, with exercise supporting it throughout.

Muscle and symptom-modifying options

Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.

Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant

What it involves

The needle is placed into the tender muscle band and a small volume of 5% glucose with 0.02-0.08% lignocaine is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling — the same technique with nothing injected — is not offered here.

What the evidence shows

Trigger-point injection reviews address confirmed myofascial pain and find heterogeneous, generally low-certainty results; they do not establish the technique as treatment for the underlying diagnosis. Condition reviewed: rheumatoid arthritis foot ankle.

Evidence source: Debrosse et al., trigger-point injection systematic review (2022)

Pairing reviewed 2026-08-30.

Where it fits for you

For rheumatoid arthritis foot ankle, this may be considered only when examination finds a separate tender muscle band reproducing part of the pain. It does not treat the primary pathology and is used to help movement or rehabilitation.

Read more about wet needling and trigger point injection
Ultrasound-guided injections Guidance means we can see the needle reach the target. What goes into the needle depends on the diagnosis. Good support

What it involves

The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis — and corticosteroid is used sparingly, for the reasons set out below.

What the evidence shows

Ultrasound improves needle-placement accuracy, but guidance is not a treatment in itself: benefit depends on a valid injectable target and what is injected. Condition reviewed: rheumatoid arthritis foot ankle.

Evidence source: Oo et al., ultrasound-guided injection systematic review (2024)

Pairing reviewed 2026-08-30.

Where it fits for you

For rheumatoid arthritis foot ankle, an ultrasound-guided injection is considered only when there is a specific diagnostic question or a separate joint, bursa, sheath or nerve target. The injectate and purpose are stated before treatment.

Read more about ultrasound-guided injections
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Not offered for this

What it involves

A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.

What the evidence shows

Not appropriate over a systemic inflammatory process, healing bone, an area of osteonecrosis or a complete tendon or ligament rupture.

Pairing reviewed 2026-08-30.

Where it fits for you

Not offered for this.

Read more about v-actor vibration therapy

Energy-based treatment options

Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.

Radial or focused shockwave? Read the overview
Radial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Only if relevant

What it involves

A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue — including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.

What the evidence shows

Shockwave reviews in myofascial pain report a possible benefit but mix protocols and often mix radial pressure wave with focused shockwave; that evidence cannot be transferred to the underlying diagnosis. Condition reviewed: rheumatoid arthritis foot ankle.

Evidence source: Wu et al., shockwave for myofascial pain review (2022)

Pairing reviewed 2026-08-30.

Where it fits for you

For rheumatoid arthritis foot ankle, radial pressure wave may be considered for a distinct superficial muscle or fascial component. It is not used as evidence of benefit for the primary diagnosis.

Read more about radial shockwave
Focused shockwave (ESWT) A true shock wave converging at depth — for tendon, joint, ligament and bone. Only if relevant

What it involves

A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form we use for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.

What the evidence shows

A systemic inflammatory condition managed medically. No role for shockwave in the disease process.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered only for a separate mechanical problem alongside it.

Read more about focused shockwave (eswt)
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Painless, no contact. Only if relevant

What it involves

You sit with the applicator positioned over the area for a short session. Painless, no gel or contact required, and usually delivered as a course — commonly alongside shockwave.

What the evidence shows

No evidence in this condition, and the rationale offered for EMTT — an effect on tendon and soft-tissue cell behaviour — does not apply to a systemic, bone or complete structural problem.

Pairing reviewed 2026-08-30.

Where it fits for you

Not part of the plan here.

Read more about emtt

Biologic and joint injection options

Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.

Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Only if relevant

What it involves

Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.

What the evidence shows

No role for PRP in the disease process here — a systemic, bone or pressure problem rather than a tendon or joint one.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered only for a separate soft-tissue problem alongside it.

Read more about platelet-rich plasma (prp)
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Only if relevant

What it involves

Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.

What the evidence shows

No role for prolotherapy in the disease process itself — this is a systemic, bone or structural problem rather than a painful ligament or tendon.

Pairing reviewed 2026-08-30.

Where it fits for you

Considered only for a separate mechanical problem alongside it.

Read more about prolotherapy
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. One small pilot trial

What it involves

One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.

What the evidence shows

This is the one rheumatoid site with a randomised trial of hyaluronic acid. Forty-four people with 75 painful rheumatoid ankle and foot joints were randomised to ultrasound-guided low-molecular-weight hyaluronic acid or lignocaine at fortnightly intervals. At four weeks the hyaluronic acid group had better pain scores (p = 0.009) and better foot function index scores on two subscales, and Doppler signal fell in 54% of injected joints against 20% of controls — though hyaluronic acid was no better than lignocaine at reducing that signal, and synovial thickening did not change in either group (Wang, Mod Rheumatol 2017). The gains were short-term and the trial was an explicitly labelled pilot. The wider overview behind the EULAR intra-articular recommendations still finds the inflammatory-arthritis data too limited to draw a firm conclusion (Rodriguez-García, RMD Open 2021).

Pairing reviewed 2026-09-12.

Where it fits for you

Worth discussing for a single ankle or forefoot joint that stays painful despite good rheumatoid disease control. Expect a few weeks to a few months of benefit rather than a lasting change, and keep it alongside rheumatological treatment rather than instead of it.

Read more about viscosupplementation

Nerve-targeted options

Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve—not simply because pain is present.

Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant

What it involves

Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.

What the evidence shows

Perineural dextrose evidence is concentrated in diagnosed peripheral compression neuropathies, particularly the upper limb; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis foot ankle.

Evidence source: Perineural dextrose for upper-limb entrapment neuropathy review (2025)

Pairing reviewed 2026-08-30.

Where it fits for you

For rheumatoid arthritis foot ankle, perineural treatment may be considered only if a separate superficial neuropathic pain pattern is found on examination. It is not treatment of the primary diagnosis.

Read more about lyftogt perineural therapy
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant

What it involves

Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.

What the evidence shows

Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: rheumatoid arthritis foot ankle.

Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)

Pairing reviewed 2026-08-30.

Where it fits for you

For rheumatoid arthritis foot ankle, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.

Read more about ultrasound-guided nerve hydrodissection

This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.

Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target.

A note on cortisone

Corticosteroid injection is reviewed separately for each diagnosis.

Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.

So we do not build treatment plans around it. Where an injection is the right call, we review the specific diagnosis and target, discuss what is being injected and why, keep the number low, and pair it with the loading work that changes the longer-term course.

When we would still consider it

  • Pain severe enough to block rehabilitation
  • A clear inflammatory or bursal target on imaging
  • A specific short-term goal — a trip, a procedure, a return to work
  • Diagnostic use, where the response tells us where the pain is coming from

When a cortisone injection is worth doing, and when it is not

Other foot, ankle & lower leg conditions

Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.

Frequently asked questions

Why do my feet hurt before anything else?
Rheumatoid arthritis characteristically starts in the small joints of the hands and feet and affects the same joints on both sides. In about 20% of people, foot and ankle symptoms are the first sign of the disease. Persistent pain, swelling and prolonged morning stiffness in both feet is a pattern that warrants blood tests and prompt rheumatology referral rather than watchful waiting.
Will orthoses or better shoes stop the disease?
No. Orthoses, supportive footwear and bracing reduce pressure and pain and can improve walking, but they do not slow the underlying disease and will not correct the shape of the foot. Only disease-modifying medication directed by a rheumatologist is designed to stop the immune system damaging the joints. The two work in parallel.
What kind of orthotic is best?
In rheumatoid arthritis, hard or rigid orthoses often place too much pressure on prominent bones and cause more pain. A custom device made of softer material that offloads those prominences is generally preferred, combined with a supportive shoe that has a less flexible sole. Softer, floppier shoes often feel better initially but tend to lead to more pain through the day.

Ready for a clearer plan for your back or musculoskeletal pain?

Book an assessment with Dr Joshua Hatch.

Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.

Book an appointment
Book an appointment with Back Pain Doctor
Book now Call